Published in Stroke on February 01, 1993
Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol (1994) 1.56
Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke (2005) 1.11
Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp Transl Stroke Med (2009) 1.11
Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia. Mediators Inflamm (2010) 1.04
Effect of anesthesia and cerebral blood flow on neuronal injury in a rat middle cerebral artery occlusion (MCAO) model. Exp Brain Res (2012) 0.89
A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injury. Cell Death Dis (2014) 0.89
Method parameters' impact on mortality and variability in rat stroke experiments: a meta-analysis. BMC Neurosci (2013) 0.88
Evaluation of the middle cerebral artery occlusion techniques in the rat by in-vitro 3-dimensional micro- and nano computed tomography. BMC Neurol (2010) 0.84
A Comparative Study of Variables Influencing Ischemic Injury in the Longa and Koizumi Methods of Intraluminal Filament Middle Cerebral Artery Occlusion in Mice. PLoS One (2016) 0.82
A microsurgical procedure for middle cerebral artery occlusion by intraluminal monofilament insertion technique in the rat: a special emphasis on the methodology. Exp Transl Stroke Med (2014) 0.81
Surgery-related thrombosis critically affects the brain infarct volume in mice following transient middle cerebral artery occlusion. PLoS One (2013) 0.80
Permanent cerebral vessel occlusion via double ligature and transection. J Vis Exp (2013) 0.78
Rat models of middle cerebral artery ischemia. Stroke (1993) 0.77
A reliable method to occlude a middle cerebral artery in Wistar rats. Stroke (1993) 0.77
Relationship of gelatinases-tight junction proteins and blood-brain barrier permeability in the early stage of cerebral ischemia and reperfusion. Neural Regen Res (2012) 0.77
Neuronal precursor cell proliferation in the hippocampus after transient cerebral ischemia: a comparative study of two rat strains using stereological tools. Exp Transl Stroke Med (2010) 0.76
Limb Remote Ischemic Postconditioning Reduces Ischemia-Reperfusion Injury by Inhibiting NADPH Oxidase Activation and MyD88-TRAF6-P38MAP-Kinase Pathway of Neutrophils. Int J Mol Sci (2016) 0.76
The Effects of Glutamate NMDA Receptor Antagonist MK-801 on Gastrointestinal Motility after Middle Cerebral Artery Occlusion in Rats. Korean J Physiol Pharmacol (2010) 0.75
Human neural stem cell therapy for chronic ischemic stroke: charting progress from laboratory to patients. Stem Cells Dev (2017) 0.75
To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke Rodents. Stroke Res Treat (2017) 0.75
Intracranial dissemination of pituitary adenomas. J Neurol Neurosurg Psychiatry (1973) 1.69
Hemifacial spasm: a prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom. J Neurol Neurosurg Psychiatry (1996) 1.66
Coincidental aneurysms with tumours of pituitary origin. J Neurol Neurosurg Psychiatry (1978) 1.59
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Ann Oncol (2005) 1.58
Is bicalutamide equivalent to goserelin for prostate volume reduction before radiation therapy? A prospective, observational study. Clin Oncol (R Coll Radiol) (2003) 1.48
Surgical treatment of giant pituitary adenomas. J Neurol Neurosurg Psychiatry (1979) 1.33
Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia (1989) 1.32
Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys (1997) 1.23
Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer. Clin Oncol (R Coll Radiol) (2005) 1.19
The Sheffield model of subarachnoid hemorrhage in rats. Stroke (1995) 1.09
Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) (1986) 1.06
Axial enlargement of the 3rd ventricle, and displacement of the brain-stem in benign aqueduct stenosis. J Neurol Neurosurg Psychiatry (1972) 1.05
Transcranial management of pituitary tumours with suprasellar extension. J Neurol Neurosurg Psychiatry (1979) 1.04
Difficulties in diagnosis of supratentorial gliomas by CAT scan. J Neurol Neurosurg Psychiatry (1979) 1.03
Feasibility of new prognostic classification for rectal cancer. J Clin Pathol (1988) 1.02
A primate model of subarachnoid hemorrhage: change in regional cerebral blood flow, autoregulation carbon dioxide reactivity, and central conduction time. Stroke (1982) 0.95
Comparison of clinical pathology parameters with two different blood sampling techniques in rats: retrobulbar plexus versus sublingual vein. Lab Anim (2000) 0.94
Thrombotic thrombocytopenic purpura (TTP) complicating leptospirosis: a previously undescribed association. J Clin Pathol (1990) 0.93
Synovial cysts of the lumbar spine: a review. Br J Neurosurg (1997) 0.89
Clinical evaluation of magnetic stimulation in cervical spondylosis. Br J Neurosurg (1989) 0.89
Metabolic syndrome and prostate cancer: a review. Clin Oncol (R Coll Radiol) (2008) 0.89
Coil embolization of giant serpentine aneurysms: report of two cases arising from the posterior cerebral artery. Br J Neurosurg (2002) 0.88
A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. Cancer Genomics Proteomics (2009) 0.88
COX-2 inhibition: a possible role in the management of prostate cancer? J Chemother (2007) 0.87
A useful technique for improving the diagnostic yield from single stereotactic biopsies of brain. Neuropathol Appl Neurobiol (1990) 0.86
Percutaneous endoscopic gastrostomy in patients with ventriculoperitoneal shunts. Br J Surg (2001) 0.84
A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy. Diabetologia (1999) 0.84
Risk analysis of treatment of unruptured aneurysms. J Neurol Neurosurg Psychiatry (2000) 0.83
Quality assurance in fractionated stereotactic radiotherapy. Radiother Oncol (1994) 0.82
Association of suprasellar meningioma with pituitary adenoma. Zentralbl Neurochir (1990) 0.81
Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer. Prostate Cancer Prostatic Dis (2004) 0.81
Intracranial pressure changes following primate subarachnoid haemorrhage. Neurol Res (1989) 0.81
Difficulties in diagnosis of intracranial meningiomas by computed tomography. J Neurol Neurosurg Psychiatry (1980) 0.81
Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization. Biochem Pharmacol (1997) 0.80
Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores. BJU Int (2004) 0.80
In vitro contractility studies of the rat middle cerebral artery after stereotactic Gamma Knife radiosurgery. Stereotact Funct Neurosurg (1996) 0.79
Primary spinal presentation of non-Hodgkin's lymphoma. A reappraisal of management and prognosis. Spine (Phila Pa 1976) (1992) 0.79
(125)Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics. BJU Int (2002) 0.79
Extradural haematoma following temporomandibular joint arthrocentesis and lavage. Br J Neurosurg (2000) 0.79
A stereoscope for image-guided surgery. Br J Neurosurg (2002) 0.78
An audit of indications and techniques for supraclavicular fossa irradiation in early breast cancer in the United Kingdom. Clin Oncol (R Coll Radiol) (2000) 0.78
An in vitro study of the pharmacological responses of rat middle cerebral artery: effects of overnight storage. J Vasc Res (1995) 0.78
Estimate of the maximum time interval between formation of cerebral aneurysm and rupture. J Neurol Neurosurg Psychiatry (2000) 0.78
Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK. A prospective study. Clin Oncol (R Coll Radiol) (2004) 0.78
Clinical features, technical problems, and results of treatment of anterior parasellar meningiomas. Acta Neurochir Suppl (Wien) (1979) 0.77
Titanium balanitis with phimosis. Dermatologica (1988) 0.77
Changes of blood flow in oestrogen-induced hyperplastic anterior pituitary lobe following bromocriptine administration. Br J Neurosurg (1987) 0.76
Proceedings: Acute haemorrhagic cerebral vasospasm in the dog: an experimental model. Br J Anaesth (1973) 0.76
Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience. Prostate Cancer Prostatic Dis (2008) 0.76
State-of-the-art: prostate LDR brachytherapy. Prostate Cancer Prostatic Dis (2008) 0.75
Measurement of Breslow depth. J Pathol (1992) 0.75
Brachytherapy: the surgeon's perspective. BJU Int (2004) 0.75
Urinary morbidity after 125I brachytherapy of the prostate. BJU Int (2004) 0.75
Letter: Spinal subarachnoid spread of pituitary adenoma. J Neurol Neurosurg Psychiatry (1974) 0.75
Thorotrast granuloma: an unexpected diagnosis. J Clin Pathol (1992) 0.75
Influence of brand of dialysis tubing of a quantitative technique for determining alkaline phosphatase activity of milk. J Assoc Off Anal Chem (1974) 0.75
Giant epidermoid cysts of the skull. Br J Neurosurg (1989) 0.75
[Synthesis of 2-chloro-4-(beta-phenylethylamino)-pyrimidine]. Acta Pol Pharm (1971) 0.75
[Value of fibroscopy in the diagnosis of abdominal pain in children]. Pediatr Pol (1983) 0.75
Changes of blood flow in the adenohypophysis of normal and estrogen pretreated Fisher rats by tamoxifen. Acta Endocrinol (Copenh) (1989) 0.75
[The use of beta-galactosidase in technology of food preparation (author's transl)]. Przegl Lek (1978) 0.75
Blood flow in diethylstilbestrol-induced anterior pituitary gland hyperplasia. Proc Soc Exp Biol Med (1986) 0.75
[Changes in the time of central neural conduction and of the amplitude of the potential N10 of the somatosensory evoked potentials in a model of subarachnoid hemorrhage in baboons]. Neurol Neurochir Pol (1985) 0.75
[Peripheral nerve dysfunction after injuries to the elbow region]. Chir Narzadow Ruchu Ortop Pol (1970) 0.75
[Technology of sugar-free protein preparates production for pharmaceutical purposes (author's transl)]. Przegl Lek (1978) 0.75
[Multidigital Dupuytren's contracture]. Chir Narzadow Ruchu Ortop Pol (1978) 0.75
[Multiple localization of fibroplasia in patients with Dupuytren's contracture]. Chir Narzadow Ruchu Ortop Pol (1977) 0.75
The diagnostic value of water-miscible contrast ventriculography. Acta Neurochir (Wien) (1972) 0.75
Primary intracerebral lymphoma: a clinicopathological analysis of 14 patients presenting over a 10-year period in Sheffield. Q J Med (1988) 0.75
[Intracranial posttraumatic hematomas and hygromas in aged and senile patients]. Neurol Neurochir Pol (1969) 0.75
[Radiological bone changes in hemophilia]. Pol Przegl Radiol Med Nukl (1968) 0.75
A clinical evaluation of computed tomography in patients with subarachnoid haemorrhage and multiple intracranial aneurysms. Zentralbl Neurochir (1989) 0.75
[Trial to bridge the defects of finger flexor tendons by polyester fibers]. Chir Narzadow Ruchu Ortop Pol (1969) 0.75
[Osteomyelitis with sickle cell anemia]. Acta Chir Orthop Traumatol Cech (1982) 0.75
["MicroVADEMECUM" program as an attempt to use AMSTRAD CPC 6128 for supporting the decisions regarding drug selection in antibiotic therapy]. Pediatr Pol (1990) 0.75
[Malignancy in Recklinghausen's neurofibromatosis]. Chir Narzadow Ruchu Ortop Pol (1972) 0.75
[Hand function before and after excision of the palmar aponeurosis in Dupuytren's contracture]. Chir Narzadow Ruchu Ortop Pol (1967) 0.75
[Magnetic stimulation of the human nervous system. Theoretic basis and clinical application]. Neurol Neurochir Pol (1991) 0.75
[Femoral neck reconstruction in dislocated varus hip]. Chir Narzadow Ruchu Ortop Pol (1976) 0.75
Traumatic intracranial hematoma and hygroma in elderly patients. Pol Med J (1969) 0.75
[Computerized tomography in aneurysms of the posterior cranial fossa]. Neurol Neurochir Pol (1992) 0.75
[Acute reticulosis with extensive cutaneous changes]. Pol Tyg Lek (Wars) (1953) 0.75
Primary plasmocytomas of the cranial vault. Acta Neurochir (Wien) (1980) 0.75
[Various problems related to the occurrence of hydrocephalus after subarachnoid hemorrhage caused by ruptured cerebral aneurysm]. Neurol Neurochir Pol (1992) 0.75
[Morphological changes in Dupuytren's contracture]. Chir Narzadow Ruchu Ortop Pol (1978) 0.75
[Osteopoikilosis with motion restriction of the joints]. Chir Narzadow Ruchu Ortop Pol (1971) 0.75
The case of TDI-induced reactive airway dysfunction syndrome with the presence of specific IgE antibodies. Allergol Immunopathol (Madr) (1994) 0.75
[A case of S1 nerve root cyst imitating diskopathy]. Neurol Neurochir Pol (1969) 0.75
The pericardium as a source of prostacyclin in the dog, ox and rat. Prostaglandins (1982) 0.75
[Studying somatosensory evoked potentials for the evaluation of surgical risk in patients operated on for aneurysms of the cerebral arteries]. Neurol Neurochir Pol (1985) 0.75
[Inflammatory cecal tumor caused by diverticulitis]. Wiad Lek (1981) 0.75
[Some properties of caseins and their genetic variants]. Postepy Biochem (1967) 0.75
[Electrophoretic studies on blood serum proteins in patients with Dupuytren's contracture]. Chir Narzadow Ruchu Ortop Pol (1967) 0.75
[Hyponatremia after subarachnoid hemorrhage caused by ruptured intracranial aneurysm]. Pol Tyg Lek (1992) 0.75
[Synthesis and tuberculostatic activity of various derivatives of 2-mercaptoimidazo [4,5-c] pyridine]. Acta Pol Pharm (1979) 0.75
[Treatment of inveterate fractures of the femur neck by McMurray's intertrochanteric osteotomy]. Chir Narzadow Ruchu Ortop Pol (1971) 0.75
[Familial occurrence of Dupuytren's contracture]. Chir Narzadow Ruchu Ortop Pol (1976) 0.75
[Problems of clinical, myelographic and operative correlations in tumors of vertebral canal]. Neurol Neurochir Pol (1969) 0.75
Cerebral blood flow changes in acute experimental haemorrhagic vasospasm. Acta Neurochir (Wien) (1976) 0.75